In an unprecedented legal move, the Federal Trade Commission (FTC) has filed a suit against a private equity firm and its portfolio company, following allegations of executing an aggressive consolidation strategy within Texas. This marks a significant extension to the community of legal professionals and corporations, given the significant rise in scrutiny over private equity-backed roll-ups.
The FTC argues that the decade-long “roll-up” strategy to consolidate anesthesiology practices has stifled competition and disrupted trade, leading to a potential violation of antitrust laws. The Federal body initiated the lawsuit on Sept. 21, 2023, opting for the U.S. District Court for the Southern District of Texas as its battleground.
A roll-up strategy typically involves acquiring multiple smaller companies within the same industry to create a single larger entity. If proved to be true, this might mark a substantial shift in the FTC’s approach towards private equity firms and their business practices.
This lawsuit underscores the need for legal professionals dealing with M&As, especially those in private equity and connected industries, to maintain a keen understanding of antitrust laws and regulations. The increased scrutiny on roll-up strategies is expected to create lasting impacts on the market dynamics and potentially reshape the private equity landscape.
For more detailed information on the case proceedings and potential implications, follow the case updates here.